Ueda T - Search Results

1

Risk factors for and prognosis of hemorrhagic cystitis after allogeneic stem cell transplantation: retrospective analysis in a single institution.

Arai Y, Maeda T, Sugiura H, Matsui H, Jo T, Ueda T, Okada K, Kawata T, Onishi T, Mizutani C, Ueda Y. Arai Y, et al. Among authors: ueda y, ueda t. Hematology. 2012 Jul;17(4):207-14. doi: 10.1179/1607845412Y.0000000010. Hematology. 2012. PMID: 22944099

2

Drug-induced interstitial pneumonitis due to low-dose lenalidomide.

Kunimasa K, Ueda T, Arita M, Maeda T, Hotta M, Ishida T. Kunimasa K, et al. Among authors: ueda t. Intern Med. 2012;51(9):1081-5. doi: 10.2169/internalmedicine.51.6651. Epub 2012 Apr 29. Intern Med. 2012. PMID: 22576392 Free article. Review.

3

Hairy Cell Leukemia with Systemic Lymphadenopathy: Detection of BRAF Mutations in Both Lymph Node and Peripheral Blood Specimens.

Okada K, Kunitomi A, Sakai K, Muranushi H, Okamoto Y, Tsukamoto T, Sugiura H, Matsui H, Jo T, Ueda T, Onishi T, Ide M, Kimura S, Notohara K, Ueda Y. Okada K, et al. Among authors: ueda y, ueda t. Intern Med. 2015;54(11):1397-402. doi: 10.2169/internalmedicine.54.2944. Epub 2015 Jun 1. Intern Med. 2015. PMID: 26027995 Free article.

4

Addition of melphalan to fludarabine/busulfan (FLU/BU4/MEL) provides survival benefit for patients with myeloid malignancy following allogeneic bone-marrow transplantation/peripheral blood stem-cell transplantation.

Ueda T, Maeda T, Kusakabe S, Fujita J, Fukushima K, Yokota T, Shibayama H, Tomiyama Y, Kanakura Y. Ueda T, et al. Int J Hematol. 2019 Feb;109(2):197-205. doi: 10.1007/s12185-018-2562-8. Epub 2018 Nov 17. Int J Hematol. 2019. PMID: 30448938

5

Curative potential of fludarabine, melphalan, and non-myeloablative dosage of busulfan in elderly patients with myeloid malignancy.

Ueda T, Jo T, Okada K, Arai Y, Sato T, Maeda T, Onishi T, Ueda Y. Ueda T, et al. Among authors: ueda y. Int J Hematol. 2020 Feb;111(2):247-255. doi: 10.1007/s12185-019-02763-2. Epub 2019 Nov 7. Int J Hematol. 2020. PMID: 31701479

6

Limbic encephalitis with antibodies to N-methyl-D-aspartate (NMDA)-type glutamate receptor after allogeneic transplantation.

Toda J, Maeda T, Akuta K, Kusakabe S, Ueda T, Fujita J, Shibayama H, Oritani K, Takahashi Y, Kanakura Y. Toda J, et al. Among authors: ueda t. Int J Hematol. 2020 Aug;112(2):254-257. doi: 10.1007/s12185-020-02859-0. Epub 2020 Mar 21. Int J Hematol. 2020. PMID: 32200528

7

First complete remission favours haploidentical haematopoietic stem cell transplantation with post-transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia.

Jo T, Ueda T, Akahoshi Y, Kondo T, Uchida N, Tanaka M, Nakamae H, Doki N, Ota S, Sawa M, Ohigashi H, Maruyama Y, Takayama N, Nishida T, Hiramoto N, Katayama Y, Kanda Y, Ichinohe T, Atsuta Y, Arai Y; Japanese Society for Transplantation and Cellular Therapy (JSTCT). Jo T, et al. Among authors: ueda t. Br J Haematol. 2024 May;204(5):1913-1919. doi: 10.1111/bjh.19372. Epub 2024 Feb 29. Br J Haematol. 2024. PMID: 38420726

8

Clinical implications of combination therapy with quizartinib and craniospinal irradiation for refractory acute myeloid leukemia positive for FMS-like tyrosine kinase 3-internal tandem duplication with central nervous system involvement.

Suga M, Fukushima K, Ueda T, Arai Y, Nakagawa S, Minami Y, Toda J, Hino A, Fujita J, Yokota T, Hosen N. Suga M, et al. Among authors: ueda t. Clin Case Rep. 2022 Feb 4;10(2):e05384. doi: 10.1002/ccr3.5384. eCollection 2022 Feb. Clin Case Rep. 2022. PMID: 35140970 Free PMC article.

9

ESAM is a novel human hematopoietic stem cell marker associated with a subset of human leukemias.

Ishibashi T, Yokota T, Tanaka H, Ichii M, Sudo T, Satoh Y, Doi Y, Ueda T, Tanimura A, Hamanaka Y, Ezoe S, Shibayama H, Oritani K, Kanakura Y. Ishibashi T, et al. Among authors: ueda t. Exp Hematol. 2016 Apr;44(4):269-81.e1. doi: 10.1016/j.exphem.2015.12.010. Epub 2016 Jan 14. Exp Hematol. 2016. PMID: 26774386 Free article.

10

Endothelial Cell-Selective Adhesion Molecule Expression in Hematopoietic Stem/Progenitor Cells Is Essential for Erythropoiesis Recovery after Bone Marrow Injury.

Sudo T, Yokota T, Okuzaki D, Ueda T, Ichii M, Ishibashi T, Isono T, Habuchi Y, Oritani K, Kanakura Y. Sudo T, et al. Among authors: ueda t. PLoS One. 2016 Apr 25;11(4):e0154189. doi: 10.1371/journal.pone.0154189. eCollection 2016. PLoS One. 2016. PMID: 27111450 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,930 results

Search Page